Best Case
15%Vaccination campaigns reach the biggest gaps quickly. School outbreaks fade faster than expected. National growth slows by early summer.
Forecast dossier
🩺 Measles keeps finding gaps in U.S. immunity
U.S. measles will likely keep rising through spring because outbreaks are already widespread and vaccine coverage has slipped below herd-immunity levels in too many places. State campaigns can slow the biggest clusters, but they are unlikely to stop new importations quickly. The result is a long tail of local outbreaks rather than one clean national peak.
Verdict: CDC counted 1,487 confirmed U.S. cases as of March 19 and said 94% were outbreak-associated, while South Carolina reported 997 cases on March 20 and Washington reported 26 cases with 92% unvaccinated. CDC also says kindergarten MMR coverage fell to 92.5% in 2024-25, below the 95% level tied to community immunity (CDC, 2026-03-20; South Carolina DPH, 2026-03-20; Washington DOH, 2026-02-26). The most likely path is more spring spread, a late-summer slowdown, and repeated local flareups into next year.
Date
Mar 24, 2026
Reliability
91
Harm potential
High
Scenario odds
Baseline
50%Spring travel seeds more cases. Big outbreaks cool slowly. Local flareups keep appearing through the year.
Adverse Case
25%Coverage gaps stay wide in key counties. Imported cases create new chains. Hospitalizations and school disruptions rise again.
Wildcard
10%A major policy push lifts coverage sharply. Outbreaks shrink faster than models expect. Measles becomes a rare import problem again.
Timeline projections
1-Year
📈 More spring spread, then a late fade
Developments: Cases keep climbing during the spring. State clinics expand response sites. The biggest outbreaks start to slow by summer.
Risks: Travel keeps seeding new chains. Some counties stay under vaccinated. Reporting lags hide active spread.
Outlook: The national curve rises first. Then it bends down unevenly. Local outbreaks remain the main story.
2-Year
🏫 School response becomes routine
Developments: Outbreak dashboards stay active. More schools use rapid vaccine outreach. Coverage improves in some hotspot counties.
Risks: Low trust communities can resist. Imported cases keep arriving. Data delays make control harder.
Outlook: The average outbreak gets smaller. Repeated flareups still happen. Elimination stays fragile, not gone.
3-Year
🛡️ Better control, same vulnerability
Developments: Public health responses get faster. Large outbreaks become less frequent. Messaging is more targeted.
Risks: Misinformation remains sticky. Small gaps can still explode. Mobility keeps import risk alive.
Outlook: Measles is controlled more often. It still returns after importations. The disease never fully leaves the map.
5-Year
🧪 Coverage improves unevenly
Developments: More states pair outreach with rapid immunization. Peak outbreak size falls. Community immunity improves in some regions.
Risks: National coverage still sits below ideal in pockets. Contact tracing can be outrun. Policy fights continue.
Outlook: Recurring clusters stay likely. They are smaller than today. The underlying weakness persists.
10-Year
📚 Rapid response becomes standard
Developments: Outbreak control looks more normalized. Schools and clinics move faster. Large waves become less common.
Risks: Mobility and misinformation still matter. Local gaps can reopen quickly. State variation remains large.
Outlook: Measles is still importable. Outbreaks are smaller. The disease is controlled, not gone.
20-Year
🔬 Smaller outbreaks, better sensors
Developments: Surveillance gets faster and more granular. Imported cases are found earlier. Large outbreaks become uncommon.
Risks: Vaccination fatigue can return. Policy swings can weaken coverage. Travel keeps the virus reintroduced.
Outlook: Measles becomes a manageable nuisance in well covered places. Small flareups still happen after imports. The key variable is coverage, not treatment.
50-Year
🌍 Rare but not forgotten
Developments: Global vaccination could nearly erase endemic transmission. Imported cases would still trigger small clusters. Digital surveillance would catch them quickly.
Risks: Misinformation can outlast generations. Coverage gaps can return after policy swings. Travel makes full eradication hard.
Outlook: Measles becomes rare in wealthy systems. Small outbreaks still happen after importations. The disease remains a test of coverage.
Planning prompts to verify
- Monitor county-level vaccination gaps
- Prepare rapid school and travel vaccination clinics
- Track outbreak size versus MMR coverage